Site Haritası

Site Haritası

New Aid to Diagnose Diabetes and Identify At-Risk Patients

Siemens Healthineers Haberleri | 06-05-2013


Practice preventive healthcare with trusted technology

Of the 371 million people living with diabetes in 2012, half were undiagnosed1. Convenient, in-office HbA1c testing can help physicians fight this epidemic on the front lines. The DCA® HbA1c test kit, used for more than two decades to monitor patients, can now be used as an aid to diagnose diabetes and identify patients at risk for developing the disease. The dual use kit, for both monitoring and diagnosing, will be available for sale in EU countries and countries not requiring any local regulatory clearances under part #10698915 after May 2013.

Siemens’ commitment to fighting the most threatening diseases includes efforts targeting chronic diseases like diabetes. Early detection and tight glycemic control help mitigate the serious conditions that accompany diabetes: heart and kidney disease, limb neuropathy, retinopathy, and stroke. More importantly, patients identified as being at risk can stop or reverse disease progression through lifestyle adjustments and/or pharmacological treatment. Availability of results at the time of visit provides healthcare providers and educators the opportunity to have meaningful, face-to-face discussions regarding treatment options. From a convenience and scheduling standpoint, it eliminates multiple visits for pre-visit blood draws or post-testing follow-up consultation.

The expanded utility of the DCA HbA1c test kit builds on Siemens track record of proven peformance. Featuring technology that has been highlighed in more than 140 clinical articles, DCA™ systems are used by three out of four phyisicians who peform HbA1c testing in the office2. The DCA Vantage® Analyzer is just one of two point-of-care HbA1c analyzers that meet NGSP performance criteria3.


Uluslararası (İngilizce): +49 69 797 6602
Bizi Pazartesi - Cuma günleri
8.00 - 17.00 saatleri arasında arayabilirsiniz.

1 International Diabetes Federation. IDF Diabetes Atlas Fifth Edition. Available at: Accessed 8/2/12.

2 GHX Market Intelligence, market data report. 4Q 2012 Report.

3 Lenters-Westra E, Slingerland RJ. Clin Chem 2010;56(1):44.

Not all product offerings are available in all countries. Not available for sale in the U.S. / Kit #10698915.

Bu bilgi yardımcı oldu mu?
Yanıtınız için teşekkür ederiz
Yorumunuzda sayı ve/veya '@' işareti olduğunu fark ettik. Sizinle iletişime geçmemiz için telefon numarası ya da e-posta adresi girmeye çalışıyorsanız lütfen bizimle e-posta formumuz aracılığıyla iletişime geçiniz.

Not: Doğrudan kişisel bir yanıt almak için lütfen bizimle e-posta formumuz üzerinden iletişime geçiniz.

Teşekkür ederiz